Close Menu
Home › IsoPlexis Wins $4M SBIR Grant From NCI

IsoPlexis Wins $4M SBIR Grant From NCI

Jun 21, 2019
|
staff reporter

NEW YORK (GenomeWeb) – Single-cell proteomics firm IsoPlexis said today that it has received a $4 million Small Business Innovation Research (SBIR) grant from the National Cancer Institute.

The Branford, Connecticut-based company said that it will use the funds to commercialize its IsoLight platform for use in quality control and guidance of CAR T therapy.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Jul
23
Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
30
Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Jul
31
Featured Webinar

Considerations and Impact of Implementing Targeted NGS in Myeloid Malignancies

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.

What's Popular?

In Cancer

  1. Guardant Health Hopes Lung Cancer Stakeholder Alignment Will Help Advance Its Liquid Biopsy Goals

    Premium

  2. Inivata to Test Liquid Biopsy Against Tissue Sequencing in French Prospective Clinical Trial

  3. Cancer Drug Discovery Firm Notable Nabs $40M in Series B Funding Round

  4. Survey of Precision Oncology Programs Finds Agreement on Testing, Divergence in Care Delivery

  5. Helomics Inks Separate Pacts With UPMC, Interpace Dx for AI-Driven Oncology Decision Making

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.